Facial Skin Red Spots, Facial Skin Red Vasculature, Sin Health, Skin Hydration, Skin Porphyrins, Skin Wrinkles
Conditions
Brief summary
The purpose of the study was to evaluate the effectiveness of the äKwä 6-step skincare system by measuring skin moisture level, fine lines and wrinkles, porphyrin count, red spots, and red vasculature counts over a 30-day period.
Detailed description
The äKwä 6-step skincare system is comprised of various skincare products intended to be applied both morning and night. Some of the notable ingredients included in the product formulas are fermented green tea water, other ferments, niacinamide, antioxidants, and a variety of natural plant extracts. The purpose of the study was to evaluate the effectiveness of the äKwä 6-step skincare system by measuring skin moisture level, fine lines and wrinkles, porphyrin count, red spots, and red vasculature counts over a 30-day period.
Interventions
OTHERäKwä skincare system products
The skincare product system tested in this study was äKwä 6-step skincare system from 4Life Research USA, LLC ( https://www.4life.com/6613461/page/äKwä). Product directions state to use the following products morning and night in sequential order: First Wave Oil-to-Foam Cleanser, Glacier Glow Four-Way Toner, Precious Pool Vitamin Essence, Ripple Refine Eye Cream, and RainBurst Moisture Cream.
OTHERcompetitor products (control)
Participants use whatever their normal daily routine of skincare products, which are commercially available competitor products from the marketplace.
Sponsors
4Life Research, LLC
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
One Active group and one Control group
Eligibility
Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes
Inclusion criteria
* Individuals could participate who were at least 18 years old and in good health.
Exclusion criteria
* had allergies or contraindications to any ingredient of products, * had a history of any acute or chronic disease that could interfere with or increase the risk of study participation * had any medical procedures, such as laser resurfacing, or plastic surgery to the test sites within the last 12 months (including Botox, Restylyn, or other fillers) * chronic skin allergies (dermatitis, eczema, psoriasis) * had been treated for skin cancer within the last 12 months or have damaged skin near the facial area (e.g., sunburn, tattoos, scars, or other disfigurations) * pregnant or planning to become pregnant in the following 12 weeks, or lactating
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Skin Hydration | 30 days | measure facial skin moisture level at pre-defined spots, with SkinFit instrument |
| Red Spot Count | 30 days | measure the number of facial red spots at predefined areas, with SkinFit instrument |
| Red Vascular Count | 30 days | measure the number of facial red vasculature at predefined areas, with SkinFit instrument |
| Porphyrin Count | 30 days | measure the number of facial porphyrin at predefined areas, with SkinFit instrument |
| Wrinkles | 30 days | measure the number of wrinkles and fine lines at predefined areas, with SkinFit instrument |
| Pores | 30 days | measure the number of skin pores at predefined areas, with SkinFit instrument |
| Texture | 30 days | measure the number of uneven skin textures, at predefined areas, with SkinFit instrument |
Countries
United States
Outcome results
None listed